Research status of commissural alignment between biological valve and autologous valve in transcatheter aortic valve replacement_West China Medical Journal

Authors：

SUN Zeyu ^1,2 , WANG Jing ¹ , LIU Changfu ¹ ,  CHEN Yundai ¹

1. Department of Cardiology, Chinese PLA General Hospital, Beijing 100853, P. R. China;
2. School of Medicine, NanKai University, Tianjin 300071, P. R. China;

Corresponding author：

CHEN Yundai, Email: cyundai@vip.163.com

Keywords：

Transcatheter aortic valve replacement; biological valve; commissural alignment

DOI：

10.7507/1002-0179.202203060

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Commissural misalignment of biological valve and autologous valve during transcatheter aortic valve replacement may affect the filling of coronary artery, reduce the feasibility of redo-aortic valve intervention and damage the valve function, which will adversely affect long-term prognosis of patients. Some studies have obtained achievement by changing the axial direction of valve and using individualized computer simulation technology to improve the alignment technology. However, there are still many unknown problems about the impact of commissural misalignment on patients, and accurate commissural alignment techniques still need to be further explored. This article systematically expounds the possible impact of commissural misalignment between biological valve and autologous valve in transcatheter aortic valve replacement, possibly effective accurate commissural alignment techniques and related research progress.

Citation： SUN Zeyu, WANG Jing, LIU Changfu, CHEN Yundai. Research status of commissural alignment between biological valve and autologous valve in transcatheter aortic valve replacement. West China Medical Journal, 2022, 37(4): 481-484. doi: 10.7507/1002-0179.202203060 Copy

1.	Gaede L, Blumenstein J, Liebetrau C, et al. Outcome after transvascular transcatheter aortic valve implantation in 2016. Eur Heart J, 2018, 39(8): 667-675.
2.	Gaede L, Blumenstein J, Liebetrau C, et al. Transvascular transcatheter aortic valve implantation in 2017. Clin Res Cardiol, 2020, 109(3): 303-314.
3.	Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med, 2019, 380(18): 1706-1715.
4.	Bekeredjian R, Szabo G, Balaban Ü, et al. Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY). Eur Heart J, 2019, 40(17): 1323-1330.
5.	潘文志, 龙愉良, 周达新, 等. 2020年经导管瓣膜治疗主要进展. 中国胸心血管外科临床杂志, 2021, 28(4): 371-375.
6.	武云龙, 王寅, 董念国. 瓣膜介入时代的思考—外科医生视角. 中国胸心血管外科临床杂志, 2021, 28(12): 1415-1419.
7.	Yudi MB, Sharma SK, Tang GHL, et al. Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement. J Am Coll Cardiol, 2018, 71(12): 1360-1378.
8.	Buzzatti N, Romano V, De Backer O, et al. Coronary access after repeated transcatheter aortic valve implantation: a glimpse into the future. JACC Cardiovasc Imaging, 2020, 13(2 Pt 1): 508-515.
9.	张怡, 熊恬园, 陈茂. 《2021 ESC/EACTS心脏瓣膜病管理指南》解读: 经导管瓣膜治疗策略的更新. 中国胸心血管外科临床杂志, 2021, 28(12): 1400-1408.
10.	Dumonteil N, Marcheix B, Lairez O, et al. Transcatheter aortic valve implantation for severe, non-calcified aortic regurgitation and narrow aortic root: description from a case report of a new approach to potentially avoid coronary artery obstruction. Catheter Cardiovasc Interv, 2013, 82(2): E124-E127.
11.	Abdelghani M, Landt M, Traboulsi H, et al. Coronary access after TAVR with a self-expanding bioprosthesis: insights from computed tomography. JACC Cardiovasc Interv, 2020, 13(6): 709-722.
12.	Ochiai T, Chakravarty T, Yoon SH, et al. Coronary access after TAVR. JACC Cardiovasc Interv, 2020, 13(6): 693-705.
13.	Rogers T, Greenspun BC, Weissman G, et al. Feasibility of coronary access and aortic valve reintervention in low-risk TAVR patients. JACC Cardiovasc Interv, 2020, 13(6): 726-735.
14.	Tang GHL, Zaid S, Gupta E, et al. Impact of initial evolut transcatheter aortic valve replacement deployment orientation on final valve orientation and coronary reaccess. Circ Cardiovasc Interv, 2019, 12(7): e008044.
15.	Bailey J, Curzen N, Bressloff NW. The impact of imperfect frame deployment and rotational orientation on stress within the prosthetic leaflets during transcatheter aortic valve implantation. J Biomech, 2017, 53: 22-28.
16.	Fuchs A, Kofoed KF, Yoon SH, et al. Commissural alignment of bioprosthetic aortic valve and native aortic valve following surgical and transcatheter aortic valve replacement and its impact on valvular function and coronary filling. JACC Cardiovasc Interv, 2018, 11(17): 1733-1743.
17.	Thyregod HGH, Ihlemann N, Jørgensen TH, et al. Five-year clinical and echocardiographic outcomes from the nordic aortic valve intervention (NOTION) randomized clinical trial in lower surgical risk patients. Circulation, 2019: 1.
18.	Tang GHL, Zaid S, Ahmad H, et al. Transcatheter valve neo-commissural overlap with coronary orifices after transcatheter aortic valve replacement. Circ Cardiovasc Interv, 2018, 11(10): e007263.
19.	Barbanti M, Costa G, Picci A, et al. Coronary cannulation after transcatheter aortic valve replacement: the RE-ACCESS study. JACC Cardiovasc Interv, 2020, 13(21): 2542-2555.
20.	Tang GHL, Sengupta A, Alexis SL, et al. Conventional versus modified delivery system technique in commissural alignment from the evolut low-risk CT substudy. Catheter Cardiovasc Interv, 2022, 99(3): 924-931.
21.	Tarantini G, Nai Fovino L, Scotti A, et al. Coronary access after transcatheter aortic valve replacement with commissural alignment: the ALIGN-ACCESS study. Circ Cardiovasc Interv, 2022, 15(2): e011045.
22.	Tang GHL, Zaid S, Fuchs A, et al. Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): impact on final valve orientation and coronary artery overlap. JACC Cardiovasc Interv, 2020, 13(9): 1030-1042.
23.	Kleiman NS. Monster under the bed?: coronary access after TAVR. JACC Cardiovasc Interv, 2021, 14(14): 1591-1593.
24.	Rodriguez-Gabella T, Voisine P, Dagenais F, et al. Long-term outcomes following surgical aortic bioprosthesis implantation. J Am Coll Cardiol, 2018, 71(13): 1401-1412.
25.	De Backer O, Landes U, Fuchs A, et al. Coronary access after TAVR-in-TAVR as evaluated by multidetector computed tomography. JACC Cardiovasc Interv, 2020, 13(21): 2528-2538.
26.	Tang GHL, Zaid S, Gupta E, et al. Feasibility of repeat TAVR after Sapien 3 TAVR: a novel classification scheme and pilot angiographic study. JACC Cardiovasc Interv, 2019, 12(13): 1290-1292.
27.	Khan JM, Dvir D, Greenbaum AB, et al. Transcatheter laceration of aortic leaflets to prevent coronary obstruction during transcatheter aortic valve replacement: concept to first-in-human. JACC Cardiovasc Interv, 2018, 11(7): 677-689.
28.	Gunning PS, Vaughan TJ, McNamara LM. Simulation of self expanding transcatheter aortic valve in a realistic aortic root: implications of deployment geometry on leaflet deformation. Ann Biomed Eng, 2014, 42(9): 1989-2001.
29.	Bieliauskas G, Wong I, Bajoras V, et al. Patient-specific implantation technique to obtain neo-commissural alignment with self-expanding transcatheter aortic valves. JACC Cardiovasc Interv, 2021, 14(19): 2097-2108.
30.	De Marco F, Casenghi M, Spagnolo P, et al. A patient-specific algorithm to achieve commissural alignment with Acurate neo: the sextant technique. Catheter Cardiovasc Interv, 2021, 98(6): E847-E854.

1. Gaede L, Blumenstein J, Liebetrau C, et al. Outcome after transvascular transcatheter aortic valve implantation in 2016. Eur Heart J, 2018, 39(8): 667-675.
2. Gaede L, Blumenstein J, Liebetrau C, et al. Transvascular transcatheter aortic valve implantation in 2017. Clin Res Cardiol, 2020, 109(3): 303-314.
3. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med, 2019, 380(18): 1706-1715.
4. Bekeredjian R, Szabo G, Balaban Ü, et al. Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY). Eur Heart J, 2019, 40(17): 1323-1330.
5. 潘文志, 龙愉良, 周达新, 等. 2020年经导管瓣膜治疗主要进展. 中国胸心血管外科临床杂志, 2021, 28(4): 371-375.
6. 武云龙, 王寅, 董念国. 瓣膜介入时代的思考—外科医生视角. 中国胸心血管外科临床杂志, 2021, 28(12): 1415-1419.
7. Yudi MB, Sharma SK, Tang GHL, et al. Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement. J Am Coll Cardiol, 2018, 71(12): 1360-1378.
8. Buzzatti N, Romano V, De Backer O, et al. Coronary access after repeated transcatheter aortic valve implantation: a glimpse into the future. JACC Cardiovasc Imaging, 2020, 13(2 Pt 1): 508-515.
9. 张怡, 熊恬园, 陈茂. 《2021 ESC/EACTS心脏瓣膜病管理指南》解读: 经导管瓣膜治疗策略的更新. 中国胸心血管外科临床杂志, 2021, 28(12): 1400-1408.
10. Dumonteil N, Marcheix B, Lairez O, et al. Transcatheter aortic valve implantation for severe, non-calcified aortic regurgitation and narrow aortic root: description from a case report of a new approach to potentially avoid coronary artery obstruction. Catheter Cardiovasc Interv, 2013, 82(2): E124-E127.
11. Abdelghani M, Landt M, Traboulsi H, et al. Coronary access after TAVR with a self-expanding bioprosthesis: insights from computed tomography. JACC Cardiovasc Interv, 2020, 13(6): 709-722.
12. Ochiai T, Chakravarty T, Yoon SH, et al. Coronary access after TAVR. JACC Cardiovasc Interv, 2020, 13(6): 693-705.
13. Rogers T, Greenspun BC, Weissman G, et al. Feasibility of coronary access and aortic valve reintervention in low-risk TAVR patients. JACC Cardiovasc Interv, 2020, 13(6): 726-735.
14. Tang GHL, Zaid S, Gupta E, et al. Impact of initial evolut transcatheter aortic valve replacement deployment orientation on final valve orientation and coronary reaccess. Circ Cardiovasc Interv, 2019, 12(7): e008044.
15. Bailey J, Curzen N, Bressloff NW. The impact of imperfect frame deployment and rotational orientation on stress within the prosthetic leaflets during transcatheter aortic valve implantation. J Biomech, 2017, 53: 22-28.
16. Fuchs A, Kofoed KF, Yoon SH, et al. Commissural alignment of bioprosthetic aortic valve and native aortic valve following surgical and transcatheter aortic valve replacement and its impact on valvular function and coronary filling. JACC Cardiovasc Interv, 2018, 11(17): 1733-1743.
17. Thyregod HGH, Ihlemann N, Jørgensen TH, et al. Five-year clinical and echocardiographic outcomes from the nordic aortic valve intervention (NOTION) randomized clinical trial in lower surgical risk patients. Circulation, 2019: 1.
18. Tang GHL, Zaid S, Ahmad H, et al. Transcatheter valve neo-commissural overlap with coronary orifices after transcatheter aortic valve replacement. Circ Cardiovasc Interv, 2018, 11(10): e007263.
19. Barbanti M, Costa G, Picci A, et al. Coronary cannulation after transcatheter aortic valve replacement: the RE-ACCESS study. JACC Cardiovasc Interv, 2020, 13(21): 2542-2555.
20. Tang GHL, Sengupta A, Alexis SL, et al. Conventional versus modified delivery system technique in commissural alignment from the evolut low-risk CT substudy. Catheter Cardiovasc Interv, 2022, 99(3): 924-931.
21. Tarantini G, Nai Fovino L, Scotti A, et al. Coronary access after transcatheter aortic valve replacement with commissural alignment: the ALIGN-ACCESS study. Circ Cardiovasc Interv, 2022, 15(2): e011045.
22. Tang GHL, Zaid S, Fuchs A, et al. Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): impact on final valve orientation and coronary artery overlap. JACC Cardiovasc Interv, 2020, 13(9): 1030-1042.
23. Kleiman NS. Monster under the bed?: coronary access after TAVR. JACC Cardiovasc Interv, 2021, 14(14): 1591-1593.
24. Rodriguez-Gabella T, Voisine P, Dagenais F, et al. Long-term outcomes following surgical aortic bioprosthesis implantation. J Am Coll Cardiol, 2018, 71(13): 1401-1412.
25. De Backer O, Landes U, Fuchs A, et al. Coronary access after TAVR-in-TAVR as evaluated by multidetector computed tomography. JACC Cardiovasc Interv, 2020, 13(21): 2528-2538.
26. Tang GHL, Zaid S, Gupta E, et al. Feasibility of repeat TAVR after Sapien 3 TAVR: a novel classification scheme and pilot angiographic study. JACC Cardiovasc Interv, 2019, 12(13): 1290-1292.
27. Khan JM, Dvir D, Greenbaum AB, et al. Transcatheter laceration of aortic leaflets to prevent coronary obstruction during transcatheter aortic valve replacement: concept to first-in-human. JACC Cardiovasc Interv, 2018, 11(7): 677-689.
28. Gunning PS, Vaughan TJ, McNamara LM. Simulation of self expanding transcatheter aortic valve in a realistic aortic root: implications of deployment geometry on leaflet deformation. Ann Biomed Eng, 2014, 42(9): 1989-2001.
29. Bieliauskas G, Wong I, Bajoras V, et al. Patient-specific implantation technique to obtain neo-commissural alignment with self-expanding transcatheter aortic valves. JACC Cardiovasc Interv, 2021, 14(19): 2097-2108.
30. De Marco F, Casenghi M, Spagnolo P, et al. A patient-specific algorithm to achieve commissural alignment with Acurate neo: the sextant technique. Catheter Cardiovasc Interv, 2021, 98(6): E847-E854.

Next Article
Interpretation of 2022 version of Chinese expert consensus on antithrombotic therapy after transcatheter aortic valve implantation

West China Medical Journal

Research status of commissural alignment between biological valve and autologous valve in transcatheter aortic valve replacement

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content